Lixing Yang to Mutation
This is a "connection" page, showing publications Lixing Yang has written about Mutation.
Connection Strength
3.521
-
A Practical Guide for Structural Variation Detection in the Human Genome. Curr Protoc Hum Genet. 2020 09; 107(1):e103.
Score: 0.288
-
Pan-cancer analysis of whole genomes. Nature. 2020 02; 578(7793):82-93.
Score: 0.277
-
Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing. Am J Hum Genet. 2016 05 05; 98(5):843-856.
Score: 0.214
-
Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23; 159(3):676-90.
Score: 0.192
-
Diverse mechanisms of somatic structural variations in human cancer genomes. Cell. 2013 May 09; 153(4):919-29.
Score: 0.174
-
Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27; 489(7417):519-25.
Score: 0.166
-
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun. 2020 09 21; 11(1):4748.
Score: 0.145
-
Genomic footprints of activated telomere maintenance mechanisms in cancer. Nat Commun. 2020 02 05; 11(1):733.
Score: 0.139
-
Combined burden and functional impact tests for cancer driver discovery using DriverPower. Nat Commun. 2020 02 05; 11(1):734.
Score: 0.139
-
Divergent mutational processes distinguish hypoxic and normoxic tumours. Nat Commun. 2020 02 05; 11(1):737.
Score: 0.139
-
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Commun. 2020 02 05; 11(1):731.
Score: 0.139
-
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat Commun. 2020 02 05; 11(1):728.
Score: 0.139
-
Pathway and network analysis of more than 2500 whole cancer genomes. Nat Commun. 2020 02 05; 11(1):729.
Score: 0.139
-
The repertoire of mutational signatures in human cancer. Nature. 2020 02; 578(7793):94-101.
Score: 0.139
-
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. Nat Cancer. 2024 Dec; 5(12):1885-1901.
Score: 0.096
-
Somatic structural variation signatures in pediatric brain tumors. Cell Rep. 2023 10 31; 42(10):113276.
Score: 0.089
-
Sex differences in oncogenic mutational processes. Nat Commun. 2020 08 28; 11(1):4330.
Score: 0.072
-
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2020 02; 578(7793):102-111.
Score: 0.069
-
An enhanced genetic model of colorectal cancer progression history. Genome Biol. 2019 08 15; 20(1):168.
Score: 0.067
-
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell. 2017 08 14; 32(2):204-220.e15.
Score: 0.058
-
The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 05; 163(4):1011-25.
Score: 0.052
-
Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18; 161(7):1681-96.
Score: 0.050
-
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98.
Score: 0.050
-
Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29; 517(7536):576-82.
Score: 0.049
-
Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11; 513(7517):202-9.
Score: 0.047
-
Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31; 511(7511):543-50.
Score: 0.047
-
High-throughput discovery of mutations in tef semi-dwarfing genes by next-generation sequencing analysis. Genetics. 2012 Nov; 192(3):819-29.
Score: 0.041
-
Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18; 487(7407):330-7.
Score: 0.041
-
Integrative pathway enrichment analysis of multivariate omics data. Nat Commun. 2020 02 05; 11(1):735.
Score: 0.035
-
The landscape of viral associations in human cancers. Nat Genet. 2020 03; 52(3):320-330.
Score: 0.035
-
Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 03 16; 543(7645):378-384.
Score: 0.028
-
Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 01 12; 541(7636):169-175.
Score: 0.028
-
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors. Clin Cancer Res. 2024 Dec 02; 30(23):5445-5458.
Score: 0.024
-
Comprehensive molecular characterization of mitochondrial genomes in human cancers. Nat Genet. 2020 03; 52(3):342-352.
Score: 0.017
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet. 2020 03; 52(3):331-341.
Score: 0.017
-
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. Cancer Cell. 2017 06 12; 31(6):820-832.e3.
Score: 0.014
-
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep. 2016 Mar 15; 14(10):2476-89.
Score: 0.013
-
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28; 164(3):550-63.
Score: 0.013
-
Cell lineage analysis in human brain using endogenous retroelements. Neuron. 2015 Jan 07; 85(1):49-59.
Score: 0.012
-
The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10; 155(2):462-77.
Score: 0.011
-
Landscape of somatic retrotransposition in human cancers. Science. 2012 Aug 24; 337(6097):967-71.
Score: 0.010
-
Detailed analysis of a contiguous 22-Mb region of the maize genome. PLoS Genet. 2009 Nov; 5(11):e1000728.
Score: 0.009